IP Library Granted Patent US 10,344,066
Granted Patent B2
US 10,344,066 · App. 15/783,056 · Granted Jul 9, 2019

Methods and compositions for increasing red blood cells

Inventors: Ravindra Kumar (Acton, MA); Naga Venkata Sai Rajasekhar Suragani (Norwood, MA); John Knopf (Carlisle, MA)
Assignee: ACCELERON PHARMA INC.
C07K14/51C07K2319/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,344,066
App. No.
15/783,056
Granted
Jul 9, 2019
Kind
B2
Abstract

In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Claims (14)

1. A method for treating anemia in a patient, the method comprising administering to a patient in need thereof a polypeptide selected from the group consisting of a BMP10 polypeptide; wherein the BMP10 polypeptide binds to ALK1 and increases red blood cell levels when administered to the patient.

2. The method of claim 1 , wherein the BMP10 polypeptide comprises an amino acid sequence that is at least 80% identical to the sequence of SEQ ID NO: 6.

3. The method of claim 1 , wherein the BMP10 polypeptide comprises an amino acid sequence that is identical to the sequence of SEQ ID NO: 6.

4. The method of claim 1 , wherein the BMP 10 polypeptide is administered in a pharmaceutical preparation.

5. The method of claim 4 , wherein the pharmaceutical preparation comprises a BMP10 prodomain polypeptide.

6. The method of claim 5 , wherein the prodomain polypeptide comprises an amino acid sequence that is at least 80% identical to the sequence of amino acids 22-316 of SEQ ID NO: 4.

7. The method of claim 5 , wherein the prodomain polypeptide comprises the amino acid sequence of amino acids 22-316 of SEQ ID NO: 4.

8. The method of claim 1 , wherein the patient has anemia associated with chronic kidney disease.

9. The method of claim 1 , wherein the patient has anemia associated with a chemotherapy treatment.

10. The method of claim 1 , wherein the chemotherapy treatment is a taxane.

11. The method of claim 1 , wherein the patient has anemia as a consequence of blood loss.

12. The method of claim 1 , wherein the BMP10 polypeptide comprises an amino acid sequence that is at least 90% identical to the sequence of SEQ ID NO: 6.

13. The method of claim 1 , wherein the BMP10 polypeptide comprises an amino acid sequence that is at least 95% identical to the sequence of SEQ ID NO: 6.

14. The method of claim 1 , wherein the BMP10 polypeptide stimulates SMAD 1/5/8 signaling.

Assignments (2)
CHANGE OF NAME Recorded Dec 21, 2021
From: SURAGANI, NAGA VENKATA SAI RAJASEKHAR
To: SURAGANI, RAJASEKHAR NAGA VENKATA SAI
Reel/Frame 058448/0569 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2017
From: KUMAR, RAVINDRA; SURAGANI, NAGA VENKATA SAI RAJASEKHAR; KNOPF, JOHN
To: ACCELERON PHARMA INC.
Reel/Frame 044648/0044 →
Continuity (3)
Continuation 13827477 · Mar 14, 2013
Provisional Application 61621154 · Apr 6, 2012
Related Publication 20180186851A1 · Jul 5, 2018